Optics News

NEW YORK – A phase 3 FDA registration trial for Ocuphire Pharma’s Nyxol yielded positive topline results for the reversal of mydriasis, according to a company executive.

Multifocal contact lenses improved visual performance in young adults and those with presbyopia, despite small but consistent degradation, according to a study published in PLoS One.

Traumatic brain injuries are not well characterized in the medical literature and are poorly understood by most health care professionals.

High add power contact lenses were more effective and stable in controlling myopia progression in children, according to a study published in Ophthalmic Research.

NEW YORK – Clinicians should consider eye misalignment leading to trigeminal dysphoria in patients with symptoms of dry eye, fatigue, occipital and neck pain radiating to the eye, and light sensitivity, Ray Corbin-Simon, OD, said in a presentation at Vision Expo East.

NEW YORK – Luneau Technology Group announced at Vision Expo East that Visionix is its new global name.

NEW YORK – Amazon Echo created Echo Frames so eyeglass wearers could be connected to the world around them in a hands-free manner, company executives told Healio at Vision Expo East.

The oculomotor system serves as a window into brain health and function because so many parts of the brain are involved in planning, coordinating and executing eye movements.

NEW ORLEANS – Johnson & Johnson Vision announced here at SECO 2022 that it is partnering with the Association for Schools and Colleges of Optometry to support the group’s initiatives to create a diverse, equitable and inclusive future for students, Chandra Mickles, OD, said.

NEW ORLEANS – Orasis Pharmaceuticals has completed two phase 3 studies of its presbyopia candidate, CSF-1, CEO Elad Kedar said here at SECO 2022.